# OnCo record limited-extensive-stage (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/limited-extensive-stage/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "limited-extensive-stage" ;
  schema:name "Limited-stage vs extensive-stage (small-cell lung cancer)"@en ;
  schema:alternateName "limited-stage"@en, "limited stage"@en, "LS-SCLC"@en, "extensive-stage"@en, "extensive stage"@en, "ES-SCLC"@en, "very limited stage"@en, "thoracic radiotherapy"@en, "consolidative thoracic radiotherapy"@en, "limited-vs-extensive-stage"@en ;
  schema:description "Small-cell lung cancer uses a two-way split instead of the usual four stages: limited (confined to one side of the chest and treatable within one radiation field, about a third of patients) or extensive (everything else)."@en ;
  schema:url <https://onco.cc/terms/limited-extensive-stage/> ;
  schema:dateModified "2026-09-09"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Small-cell_carcinoma> ;
  schema:citation <https://en.wikipedia.org/wiki/Small-cell_carcinoma> ;
  onco:related <https://onco.cc/terms/chemoradiation/>, <https://onco.cc/technologies/prophylactic-cranial-irradiation/>, <https://onco.cc/terms/consolidation-therapy/> ;
  onco:cancers <https://onco.cc/cancers/sclc/> ;
  onco:sections <https://onco.cc/fronts/radiation/>, <https://onco.cc/fronts/chemotherapy/> ;
  onco:drugs <https://onco.cc/drugs/durvalumab/>, <https://onco.cc/drugs/atezolizumab/>, <https://onco.cc/drugs/tarlatamab/> ;
  onco:trials <https://onco.cc/trials/adriatic/>, <https://onco.cc/trials/convert/> .
